Drugs.com - New Drug Approvals

FDA Approves mNEXSPIKE (COVID-19 Vaccine, mRNA) to Prevent COVID-19

CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and...

Jun 3, 2025 - 08:15
 0
FDA Approves mNEXSPIKE (COVID-19 Vaccine, mRNA) to Prevent COVID-19
CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and...
Read More

Tags:

Previous Article

Candela C-8 Electric Boat Makes Historic First Crossing from Europe to Africa

Next Article

BYD’s Commercial Vehicle Sales Up 531% in May — CHARTS

Related Posts

FDA Approves Merck’s Welireg (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)

FDA Approves Merck’s Welireg (belzutifan) for the Treat...

May 15, 2025  0

FDA Approves HemiClor (chlorthalidone) for the Treatment of Hypertension

FDA Approves HemiClor (chlorthalidone) for the Treatmen...

May 18, 2025  0

U.S. Food and Drug Administration Updates Camzyos (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

U.S. Food and Drug Administration Updates Camzyos (mava...

May 12, 2025  0